Robert Nicol

Board Member at Design Pharmaceuticals

Robert Nicol is the Director of Technology Development at the Broad Institute of MIT and Harvard.

Robert's research group develops tools to engineer biology across three core areas: massively parallel DNA synthesis, biomolecule library generation, and ultra-high throughput methods to screen these libraries for machine learning. These tools require integration of systems engineering, microfluidics, semiconductors, synthetic biology, and sequencing. Robert has been an Investigator on multiple large scale advanced biotechnology development programs for DARPA, IARPA, and NIH. Robert is also the co-founder of multiple biotechnology companies focused on applying these tools to create advanced therapeutics for the benefit of patients.


Timeline

  • Board Member

    Current role